Nantahala Capital Management - Q2 2022 holdings

$1.99 Billion is the total value of Nantahala Capital Management's 124 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 27.9% .

 Value Shares↓ Weighting
IWM SellISHARES TRput$423,400,000
-23.6%
2,500,000
-7.4%
21.23%
-13.4%
LLY NewLILLY ELI & COput$113,480,000350,000
+100.0%
5.69%
ESTA SellESTABLISHMENT LABS HLDGS INC$109,162,000
-24.6%
2,007,385
-6.6%
5.47%
-14.6%
QURE BuyUNIQURE NV$57,612,000
+13.4%
3,090,757
+9.9%
2.89%
+28.5%
SGMS SellLIGHT & WONDER INC$52,222,000
-22.3%
1,111,338
-2.9%
2.62%
-12.0%
SNDX SellSYNDAX PHARMACEUTICALS INC$51,238,000
+9.5%
2,663,087
-1.1%
2.57%
+24.1%
COST NewCOSTCO WHSL CORP NEWput$47,928,000100,000
+100.0%
2.40%
IMAX BuyIMAX CORP$46,100,000
-8.7%
2,729,441
+2.3%
2.31%
+3.4%
MLHR BuyMILLERKNOLL INC$44,862,000
-20.0%
1,707,739
+5.2%
2.25%
-9.3%
TA  TRAVELCENTERS OF AMERICA INC$43,865,000
-19.8%
1,272,5700.0%2.20%
-9.1%
CDXS BuyCODEXIS INC$43,096,000
-38.2%
4,120,098
+21.8%
2.16%
-30.0%
CASH BuyMETA FINL GROUP INC$38,108,000
-20.2%
985,459
+13.3%
1.91%
-9.6%
TNL BuyTRAVEL PLUS LEISURE CO$37,860,000
-24.7%
975,281
+12.4%
1.90%
-14.6%
IMAX  IMAX CORPcall$37,011,000
-10.8%
2,191,3000.0%1.86%
+1.1%
DXPE BuyDXP ENTERPRISES INC$36,910,000
+14.6%
1,205,031
+1.3%
1.85%
+29.9%
TNL  TRAVEL PLUS LEISURE COcall$35,679,000
-33.0%
919,1000.0%1.79%
-24.1%
LXFR BuyLUXFER HOLDINGS PLC$35,196,000
-6.2%
2,327,801
+4.3%
1.76%
+6.4%
AMPH  AMPHASTAR PHARMACEUTICALS INput$34,790,000
-3.1%
1,000,0000.0%1.74%
+9.9%
COST NewCOSTCO WHSL CORP NEW$34,266,00071,495
+100.0%
1.72%
ATGE BuyADTALEM GLOBAL ED INCput$32,373,000
+117.9%
900,000
+80.0%
1.62%
+147.0%
RMR BuyRMR GROUP INCcl a$27,517,000
-8.0%
970,623
+0.9%
1.38%
+4.3%
IMTX BuyIMMATICS N.V$27,191,000
+15.6%
3,121,759
+6.0%
1.36%
+31.0%
KROS BuyKEROS THERAPEUTICS INC$25,196,000
-43.3%
911,901
+11.6%
1.26%
-35.7%
RDVT BuyRED VIOLET INC$24,595,000
-31.6%
1,291,771
+2.4%
1.23%
-22.5%
SYK BuySTRYKER CORPORATIONput$23,872,000
+31.9%
120,000
+77.3%
1.20%
+49.4%
DRI BuyDARDEN RESTAURANTS INCput$22,624,000
+70.2%
200,000
+100.0%
1.13%
+92.9%
PTON BuyPELOTON INTERACTIVE INC$22,481,000
+44.1%
2,448,878
+314.8%
1.13%
+63.3%
DHX BuyDHI GROUP INC$20,568,000
-10.2%
4,138,483
+7.6%
1.03%
+1.8%
PAYA SellPAYA HOLDINGS INC$19,445,000
-19.3%
2,959,599
-28.0%
0.98%
-8.5%
GDEN SellGOLDEN ENTMT INC$19,181,000
-52.2%
484,974
-29.8%
0.96%
-45.8%
RH NewRH$19,103,00090,000
+100.0%
0.96%
HLF BuyHERBALIFE NUTRITION LTDcall$17,744,000
+118.3%
867,700
+224.1%
0.89%
+147.2%
MAX BuyMEDIAALPHA INCcl a$16,160,000
+123.2%
1,640,624
+275.0%
0.81%
+153.1%
ALTG SellALTA EQUIPMENT GROUP INC$15,003,000
-32.8%
1,672,545
-7.4%
0.75%
-23.9%
QURE SellUNIQURE NVcall$14,912,000
-7.3%
800,000
-10.1%
0.75%
+5.1%
AUTL BuyAUTOLUS THERAPEUTICS PLCspon ads$14,554,000
-19.7%
5,142,855
+18.3%
0.73%
-9.0%
APEN SellAPOLLO ENDOSURGERY INC$13,589,000
-39.7%
3,723,010
-0.1%
0.68%
-31.7%
LYRA NewLYRA THERAPEUTICS INC$13,389,0002,369,668
+100.0%
0.67%
RDI SellREADING INTL INCcl a$11,578,000
-16.2%
3,207,247
-0.6%
0.58%
-4.9%
AMYT BuyAMRYT PHARMA PLCsponsored ads$10,922,000
+23.2%
1,562,458
+45.8%
0.55%
+39.8%
BuyDARIOHEALTH CORP$10,627,000
+6.0%
1,730,810
+0.9%
0.53%
+20.3%
PTON BuyPELOTON INTERACTIVE INCcall$10,452,000
-55.5%
1,138,600
+28.1%
0.52%
-49.6%
BBQ SellBBQ HLDGS INC$9,881,000
-31.4%
948,254
-0.3%
0.50%
-22.3%
SMLR SellSEMLER SCIENTIFIC INC$9,767,000
-44.8%
346,606
-2.9%
0.49%
-37.4%
IIII SellINSU ACQUISITION CORP III$9,655,000
-1.2%
980,183
-1.5%
0.48%
+12.0%
VMD BuyVIEMED HEALTHCARE INC$9,226,000
+43.2%
1,714,926
+32.5%
0.46%
+62.5%
SellARYA SCIENCES ACQUISITN CORP$8,384,000
-0.5%
862,566
-0.4%
0.42%
+12.6%
GOGO NewGOGO INCput$8,095,000500,000
+100.0%
0.41%
RNG NewRINGCENTRAL INCcl a$7,839,000150,000
+100.0%
0.39%
CBAY BuyCYMABAY THERAPEUTICS INC$7,801,000
+32.4%
2,644,306
+39.6%
0.39%
+49.8%
HERA SellFTAC HERA ACQUISITION CORP$7,714,000
-1.5%
787,130
-1.6%
0.39%
+11.5%
FBIO SellFORTRESS BIOTECH INC$7,356,000
-38.8%
8,758,648
-0.9%
0.37%
-30.6%
CNCE NewCONCERT PHARMACEUTICALS INC$6,988,0001,659,840
+100.0%
0.35%
 PAR TECHNOLOGY CORPnote 2.875% 4/1$6,675,000
-4.0%
5,785,0000.0%0.34%
+8.8%
SRL SellSCULLY ROYALTY LTD$6,189,000
-18.4%
771,196
-0.2%
0.31%
-7.7%
TSHA BuyTAYSHA GENE THERAPIES INC$6,114,000
-29.7%
1,643,438
+23.2%
0.31%
-20.3%
PRDO NewPERDOCEO ED CORPput$5,890,000500,000
+100.0%
0.30%
SBTX BuySILVERBACK THERAPEUTICS INC$5,877,000
+86.5%
1,386,138
+51.7%
0.30%
+112.2%
APEN NewAPOLLO ENDOSURGERY INCcall$5,840,0001,600,000
+100.0%
0.29%
ONTF BuyON24 INC$5,413,000
+7.2%
570,403
+48.5%
0.27%
+21.5%
SellAPTOSE BIOSCIENCES INC$5,367,000
-46.1%
7,232,676
-1.2%
0.27%
-39.0%
CBIO BuyCATALYST BIOSCIENCES INC$4,906,000
+207.0%
2,755,903
+13.8%
0.25%
+246.5%
BuyAURA BIOSCIENCES INC$4,863,000
-26.8%
343,215
+13.7%
0.24%
-17.0%
SYK NewSTRYKER CORPORATION$4,575,00023,000
+100.0%
0.23%
SSKN  STRATA SKIN SCIENCES INC$4,397,000
-34.6%
4,575,8120.0%0.22%
-26.2%
IWM SellISHARES TRrussell 2000 etf$4,043,000
-94.6%
23,873
-93.5%
0.20%
-93.9%
CRIS BuyCURIS INC$3,572,000
-39.4%
3,628,162
+46.4%
0.18%
-31.4%
INMD NewINMODE LTD$3,544,000158,154
+100.0%
0.18%
SellAVALO THERAPEUTICS INC$3,355,000
-30.2%
6,710,327
-2.0%
0.17%
-21.1%
SellAKUMIN INC$3,325,000
-46.3%
5,545,233
-0.6%
0.17%
-39.1%
RILY SellB. RILEY FINANCIAL INC$3,257,000
-40.7%
77,083
-1.8%
0.16%
-32.9%
ARYD SellARYA SCIENCES ACQU CORP IVcl a$3,168,000
-0.8%
322,929
-0.9%
0.16%
+12.8%
BRPM SellB RILEY PRINCIPAL 150 MERGER$2,965,000
-1.0%
297,727
-1.3%
0.15%
+12.9%
RMBL NewRUMBLEON INC$2,942,000200,000
+100.0%
0.15%
MACK SellMERRIMACK PHARMACEUTICALS IN$2,924,000
-10.6%
491,509
-4.9%
0.15%
+1.4%
PWP  PERELLA WEINBERG PARTNERS$2,931,000
-38.3%
502,6760.0%0.15%
-30.0%
STIM SellNEURONETICS INC$2,463,000
-7.6%
767,400
-12.8%
0.12%
+5.1%
KR NewKROGER COcall$2,366,00050,000
+100.0%
0.12%
NPCE SellNEUROPACE INC$2,368,000
-40.6%
478,438
-1.4%
0.12%
-32.4%
CDTX SellCIDARA THERAPEUTICS INC$2,355,000
-42.9%
4,819,090
-2.7%
0.12%
-35.5%
IMTXW  IMMATICS N.V*w exp 07/01/202$2,113,000
+21.4%
1,035,6130.0%0.11%
+37.7%
NAUT SellNAUTILUS BIOTECHNOLOGY INC$2,111,000
-45.6%
784,798
-12.2%
0.11%
-38.4%
AGLE BuyAEGLEA BIOTHERAPEUTICS INC$1,958,000
-73.4%
3,877,311
+21.1%
0.10%
-69.9%
VRM  VROOM INCcall$1,875,000
-53.0%
1,500,0000.0%0.09%
-46.9%
SFT SellSHIFT TECHNOLOGIES INCcl a$1,792,000
-78.2%
2,662,933
-28.6%
0.09%
-75.2%
SLNO  SOLENO THERAPEUTICS INC$1,675,000
-20.4%
9,436,5120.0%0.08%
-9.7%
ZVO SellZOVIO INC$1,606,000
-25.1%
1,655,335
-36.7%
0.08%
-14.7%
FVAM Sell5 01 ACQUISITION CORP$1,554,000
-2.9%
157,044
-3.3%
0.08%
+9.9%
PAYO  PAYONEER GLOBAL INC$1,511,000
-12.1%
385,3660.0%0.08%0.0%
IDWM SellIDW MEDIA HLDGS INCcl b$1,411,000
-31.1%
1,052,852
-5.9%
0.07%
-22.0%
ANGN SellANGION BIOMEDICA CORP$1,289,000
-48.2%
1,131,001
-3.6%
0.06%
-40.9%
SellHYPERFINE INC$1,215,000
-42.5%
544,930
-8.6%
0.06%
-34.4%
KROS  KEROS THERAPEUTICS INCcall$1,158,000
-49.2%
41,9000.0%0.06%
-42.6%
IMAC SellIMAC HLDGS INC$1,044,000
-54.8%
1,259,379
-43.8%
0.05%
-49.0%
LVTX SellLAVA THERAPEUTICS NV$953,000
-35.2%
322,980
-3.3%
0.05%
-26.2%
ALEC SellALECTOR INC$937,000
-30.6%
92,176
-2.7%
0.05%
-21.7%
IMV SellIMV INC$933,000
-64.6%
1,424,676
-23.7%
0.05%
-59.5%
ACER SellACER THERAPEUTICS INC$934,000
-58.6%
741,010
-4.7%
0.05%
-53.0%
 FARADAY FUTRE INTLGT ELCTR I$910,000
-47.9%
350,0000.0%0.05%
-40.3%
SellHELIOGEN INC$916,000
-72.9%
433,909
-32.6%
0.05%
-69.3%
XGN SellEXAGEN INC$896,000
-29.9%
156,135
-2.0%
0.04%
-21.1%
EAR NewEARGO INC$774,0001,028,965
+100.0%
0.04%
SellLUCID DIAGNOSTICS INC$698,000
-34.2%
308,978
-2.0%
0.04%
-25.5%
BuyUNICYCIVE THERAPEUTICS INC$606,000
-26.6%
729,680
+13.9%
0.03%
-18.9%
CDXS NewCODEXIS INCcall$523,00050,000
+100.0%
0.03%
SellCOGNITION THERAPEUTICS INC$407,000
-24.6%
192,752
-1.9%
0.02%
-16.7%
SellIN8BIO INC$359,000
-70.7%
148,801
-57.8%
0.02%
-66.7%
MILE SellMETROMILE INC$298,000
-78.4%
325,002
-68.9%
0.02%
-75.4%
TACT SellTRANSACT TECHNOLOGIES INC$279,000
-44.6%
69,991
-1.9%
0.01%
-36.4%
CUE SellCUE BIOPHARMA INC$250,000
-97.7%
100,464
-95.5%
0.01%
-97.3%
PWPPW  PERELLA WEINBERG PARTNERS*w exp 12/31/202$264,000
-67.9%
409,1280.0%0.01%
-63.9%
SellWEJO GROUP LIMITED$158,000
-81.6%
132,728
-38.3%
0.01%
-78.9%
NewSITIO ROYALTIES CORP*w exp 08/23/202$93,000582,350
+100.0%
0.01%
HERAW  FTAC HERA ACQUISITION CORP*w exp 02/28/202$53,000
-45.4%
222,9490.0%0.00%
-25.0%
MILEW  METROMILE INC*w exp 02/09/202$57,000
-13.6%
507,4600.0%0.00%0.0%
BRPMW BuyB RILEY PRINCIPAL 150 MERGER*w exp 03/01/202$69,000
-36.7%
185,653
+53.8%
0.00%
-40.0%
 TC BIOPHARM HOLDINGS PLC*w exp 02/08/202$56,000
-52.1%
235,2940.0%0.00%
-40.0%
SellFINTECH ACQUISITION CORP VI*w exp 03/31/202$39,000
-72.7%
240,600
-3.8%
0.00%
-66.7%
FTCVW  FINTECH ACQUISITION CORP V*w exp 12/31/202$30,000
-90.5%
333,3310.0%0.00%
-85.7%
IIIIW  INSU ACQUISITION CORP III*w exp 12/31/202$30,000
-55.2%
333,3320.0%0.00%
-33.3%
KTRA SellKINTARA THERAPEUTICS INC$32,000
-87.9%
116,234
-82.5%
0.00%
-83.3%
RFL NewRAFAEL HLDGS INC$36,00019,435
+100.0%
0.00%
 QUALTEK SERVICES INC*w exp 02/14/202$15,000
-73.2%
96,2440.0%0.00%
-50.0%
SellGUARDFORCE AI CO LTD*w exp 10/01/202$19,000
-86.6%
154,205
-58.8%
0.00%
-83.3%
OCGN ExitOCUGEN INC$0-16,571
-100.0%
-0.00%
ExitFALCON MINERALS CORP*w exp 07/21/202$0-674,561
-100.0%
-0.01%
HTGM ExitHTG MOLECULAR DIAGNOSTICS IN$0-285,963
-100.0%
-0.02%
GLMD ExitGALMED PHARMACEUTICALS LTD$0-258,957
-100.0%
-0.02%
ELOX ExitELOXX PHARMACEUTICALS INC$0-774,767
-100.0%
-0.02%
AKBA ExitAKEBIA THERAPEUTICS INCcall$0-965,800
-100.0%
-0.03%
ExitTANGO THERAPEUTICS INC$0-98,794
-100.0%
-0.03%
WVE ExitWAVE LIFE SCIENCES LTD$0-819,101
-100.0%
-0.07%
PAYA ExitPAYA HOLDINGS INCcall$0-300,000
-100.0%
-0.08%
W ExitWAYFAIR INCcl a$0-34,688
-100.0%
-0.17%
KURA ExitKURA ONCOLOGY INCcall$0-240,900
-100.0%
-0.17%
HCA ExitHCA HEALTHCARE INC$0-35,600
-100.0%
-0.40%
FTCV ExitFINTECH ACQUISITION CORP V$0-958,137
-100.0%
-0.42%
ExitFINTECH ACQUISITION CORP VI$0-999,992
-100.0%
-0.43%
XBI ExitSPDR SER TRput$0-250,000
-100.0%
-0.99%
IMXI ExitINTERNATIONAL MNY EXPRESS IN$0-1,425,985
-100.0%
-1.30%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

About Nantahala Capital Management

Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.

Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.

Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.

Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR42Q3 202327.2%
CODEXIS INC42Q3 20233.9%
PATHWARD FINANCIAL INC35Q3 20236.3%
SCIENTIFIC GAMES CORP34Q3 20225.3%
DOVER MOTORSPORTS INC34Q3 20210.5%
GOLDEN ENTMT INC33Q3 20232.1%
QAD INC32Q3 20212.6%
SCIENTIFIC GAMES CORP31Q4 20217.7%
DOLBY LABORATORIES INC31Q4 20205.6%
LINCOLN EDL SVCS CORP31Q4 20210.7%

View Nantahala Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Nantahala Capital Management Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AYTU BIOPHARMA, INCJune 16, 20231,086,81219.7%
Acer Therapeutics Inc.February 14, 20231,226,1917.5%
Aeglea BioTherapeutics, Inc.February 14, 20234,611,3027.5%
AKUMIN INC.February 14, 20232,206,9602.5%
ALTA EQUIPMENT GROUP INC.February 14, 20231,188,9853.7%
Apollo Endosurgery, Inc.February 14, 20234,056,6279.9%
Autolus Therapeutics plcFebruary 14, 20237,782,0184.7%
Bioventus Inc.February 14, 20233,168,5745.1%
CATALYST BIOSCIENCES, INC.February 14, 2023438,0551.4%
Drive Shack Inc.February 14, 20236,500,0007.0%

View Nantahala Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
42024-03-21
42024-03-15
SC 13G2024-03-11
13F-HR/A2024-02-15
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Nantahala Capital Management's complete filings history.

Compare quarters

Export Nantahala Capital Management's holdings